Thus, our study suggest abrogation of autophagy by autophagy inhibitors, which is considered as an attractive approach for breast cancer therapy23,24, may have therapeutic value in the treatment of breast cancer patients with low RPS27L expression. The gene discussed is RPS27L; the disease is breast cancer.